A pharmacodynamic model of portal hypertension in isolated perfused rat liver
about
Salvianolic Acid B reducing portal hypertension depends on macrophages in isolated portal perfused rat livers with chronic hepatitis.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis
P2860
A pharmacodynamic model of portal hypertension in isolated perfused rat liver
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A pharmacodynamic model of portal hypertension in isolated perfused rat liver
@ast
A pharmacodynamic model of portal hypertension in isolated perfused rat liver
@en
type
label
A pharmacodynamic model of portal hypertension in isolated perfused rat liver
@ast
A pharmacodynamic model of portal hypertension in isolated perfused rat liver
@en
prefLabel
A pharmacodynamic model of portal hypertension in isolated perfused rat liver
@ast
A pharmacodynamic model of portal hypertension in isolated perfused rat liver
@en
P2093
P2860
P356
P1476
A pharmacodynamic model of portal hypertension in isolated perfused rat liver
@en
P2093
Da-Yong Cai
Peng-Tao Li
Tao-Tao Zhang
Xue-Yan Xu
P2860
P304
P356
10.3748/WJG.V18.I5.472
P407
P577
2012-02-01T00:00:00Z